{"id":"nct:NCT07221253","kind":"trial","title":"A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)","authors":["AstraZeneca"],"author_count":1,"year":2025,"published":"2025-10-27","venue":"ClinicalTrials.gov","cited_by":null,"doi":null,"arxiv_id":null,"nct_id":"NCT07221253","source_url":"https://clinicaltrials.gov/study/NCT07221253","archive_url":"https://space-kitty.com/papers/nct:NCT07221253","updated":"2026-09-28","pmid":null,"pmcid":null,"openalex_id":null,"pdf_url":null,"abstract":"The purpose of this study is to measure the efficacy and safety of rilvegostomig with gemcitabine plus cisplatin vs. durvalumab with gemcitabine plus cisplatin as first line treatment for patients with advanced BTC.","abstract_license":"ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters","license":"ClinicalTrials.gov terms (attribution, processing date, modifications noted)","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Biliary Tract Cancer"],"details":{"acronym":"AB02","status":"RECRUITING","phase":"PHASE3","study_type":"INTERVENTIONAL","enrollment":1100,"sponsor":"AstraZeneca","conditions":["Biliary Tract Cancer"],"interventions":["DRUG: Rilvegostomig","DRUG: Durvalumab","DRUG: Gemcitabine/Cisplatin"],"start_date":"2025-12-04","start_date_type":"ACTUAL","primary_completion_date":"2029-07-31","has_results":false,"data_source":"ClinicalTrials.gov","data_processed":"2026-10-29T09:00:05","modifications":"selected fields only; whitespace normalized; brief summary truncated to 2,000 characters"},"provenance":"clinicaltrials","attribution":"Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}